CLASS II ONGOING Drug recall · Reported 28 Aug 2024 · FDA Enforcement Report

Lidocaine HCl Injection, 2% (20mg per mL) (100 mg per syringe recalled

Fagron Compounding Services is recalling Lidocaine HCl Injection, 2% (20mg per mL) (100 mg per syringe, distributed nationwide in the US. The recall was initiated on 15 Aug 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot#: C274-000037397, C274-000037398, C274-000037399, C274-000037400, Exp. Date 10/14/2024.

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0636-2024
FDA event ID
95146
Recalling firm
Fagron Compounding Services, Wichita, KS
Classification
Class II
Status
Ongoing
Recall initiated
15 Aug 2024
FDA classified
16 Aug 2024
Reported
28 Aug 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility
Drug class
Pain Medication

Timeline

15 Aug 2024Recall initiated by company
16 Aug 2024Classified by FDA+1 day
28 Aug 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Lidocaine HCl Injection, 2% (20mg per mL) (100 mg per 5 mL) per syringe, Rx only, Fagron Sterile Services, 8710 E. 34th St, N. Wichita, KS 57226.

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility

Which lots are affected?

Lot#: C274-000037397, C274-000037398, C274-000037399, C274-000037400, Exp. Date 10/14/2024.

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Fagron Compounding Services

All 13

Other Lidocaine recalls

All 119